View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/HRSA | RIN: 0906-AA99 | Publication ID: 2012 |
Title: ●340B Drug Pricing Program: Patient Definition and Other Eligibility Requirements | |
Abstract: This proposed rule would provide covered entities participating in the 340B Drug Pricing Program with more explicit guidance regarding the relationship that must exist between a covered entity and an individual to establish and demonstrate covered entity responsibility for care of its 340B patients. | |
Agency: Department of Health and Human Services(HHS) | Priority: Info./Admin./Other |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Long-Term Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: Not Yet Determined (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: 42 USC 256b 42 USC 216 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Krista Pedley Director, Office of Pharmacy Affairs Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau, 5600 Fishers Lane, Rockville, MD 20857 Phone:301 594-4353 Email: krista.pedley@hrsa.hhs.gov |